{"database": "lobbying", "table": "lobbying_activities", "rows": [[2593362, "16fbec92-4dbc-4f83-8385-f26caebfcd6b", "1A", "WELSH ROSE, LLC", 401104285, "ALNYLAM PHARMACEUTICALS, INC.", 2021, "first_quarter", "MMM", "PL 117-2, The American Rescue Plan Act of 2021; REFUND Act; home infusion issues and April 2021 Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).", "HOUSE OF REPRESENTATIVES", 40000, null, 0, 0, "2021-04-12T12:24:54.327000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2593362"], "units": {}, "query_ms": 0.39502499566879123, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}